Circio Holding ASA

TA50

Company Profile

  • Business description

    Circio Holding ASA is a biotechnology company developing circular RNA expression technology for gene and cell therapy applications. It has developed a circular RNA (circRNA) vector expression platform known as circVec, which is based on modular genetic constructs designed for circRNA production within target cells. The platform is being developed for applications including genetic medicine, cell therapy, and chronic disease treatment. The company's activities also include the development of RNA, DNA, and viral therapeutic technologies related to gene expression and protein production.

  • Contact

    c/o Mesh Community AS
    Tordenskiolds Gate 2
    Oslo0160
    NOR

    T: +47 92951788

    https://www.circio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    11

Stocks News & Analysis

stocks

Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?

We’re expecting another beat-and-raise quarter, while watching the roadmap and discussions of its financing and partnership deals.
stocks

Wide moat airport share steps up its investments

Profits flatten as airport ramps up redevelopment.
stocks

Top ASX income share sees steady dividend growth

Income appeal backed by growth projects.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,323.9016.400.18%
CAC 408,484.4331.340.37%
DAX 4026,136.56153.520.59%
Dow JONES (US)53,277.01517.800.98%
FTSE 10010,816.5668.400.64%
HKSE25,489.10520.36-2.00%
NASDAQ26,180.46113.290.43%
Nikkei 22565,968.7147.65-0.07%
NZX 50 Index13,927.9344.73-0.32%
S&P 5007,674.3733.210.43%
S&P/ASX 2009,111.3018.100.20%
SSE Composite Index3,873.0032.20-0.82%

Market Movers